Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of SJP-0008 in central retinal artery occlusion
jRCT2021190013Phase 2Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SJP-0008 in central retinal artery occlusion (CRAO) (2 arms), sponsored by Japan Agency for Medical Research and Development. Started Jan 2020; status: active, not recruiting.
02
Drugs
SJP-0008
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on jRCT2021190013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2021190013.